PT Suparma Tbk (IDX:SPMA)
Indonesia
· Delayed Price · Currency is IDR 272.00
+4.00 (1.49%)
Mar 27, 2025, 3:27 PM WIB
PT Suparma Tbk Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 2,729,636 | 2,658,521 | 3,138,054 | 2,794,453 | 2,151,495 | Upgrade
|
| Revenue Growth (YoY) | 2.67% | -15.28% | 12.30% | 29.88% | -14.42% | Upgrade
|
| Cost of Revenue | 2,316,788 | 2,196,750 | 2,427,849 | 2,212,061 | 1,765,848 | Upgrade
|
| Gross Profit | 412,849 | 461,771 | 710,205 | 582,392 | 385,647 | Upgrade
|
| Selling, General & Admin | 217,285 | 206,708 | 183,723 | 169,709 | 154,023 | Upgrade
|
| Other Operating Expenses | 5,517 | - | 613.51 | - | 2,560 | Upgrade
|
| Operating Expenses | 222,802 | 206,708 | 184,337 | 169,709 | 156,583 | Upgrade
|
| Operating Income | 190,046 | 255,063 | 525,868 | 412,683 | 229,064 | Upgrade
|
| Interest Expense | -38,996 | -34,876 | -32,682 | -31,355 | -33,558 | Upgrade
|
| Interest & Investment Income | - | 5,809 | 4,247 | 1,344 | 2,783 | Upgrade
|
| Currency Exchange Gain (Loss) | -29,452 | 9,086 | -65,997 | 335.94 | -2,217 | Upgrade
|
| Other Non Operating Income (Expenses) | 12,844 | 3,042 | 632.25 | 3,373 | -568.22 | Upgrade
|
| EBT Excluding Unusual Items | 134,443 | 238,124 | 432,068 | 386,381 | 195,503 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -461.94 | -622.47 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 186.72 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | -8,871 | - | Upgrade
|
| Pretax Income | 134,443 | 237,849 | 431,446 | 377,510 | 195,503 | Upgrade
|
| Income Tax Expense | 29,604 | 59,190 | 95,308 | 83,184 | 32,979 | Upgrade
|
| Net Income | 104,839 | 178,658 | 336,138 | 294,326 | 162,525 | Upgrade
|
| Net Income to Common | 104,839 | 178,658 | 336,138 | 294,326 | 162,525 | Upgrade
|
| Net Income Growth | -41.32% | -46.85% | 14.21% | 81.10% | 24.06% | Upgrade
|
| Shares Outstanding (Basic) | 3,177 | 3,154 | 3,154 | 3,154 | 3,154 | Upgrade
|
| Shares Outstanding (Diluted) | 3,177 | 3,154 | 3,154 | 3,154 | 3,154 | Upgrade
|
| Shares Change (YoY) | 0.72% | - | - | - | - | Upgrade
|
| EPS (Basic) | 33.00 | 56.64 | 106.57 | 93.32 | 51.53 | Upgrade
|
| EPS (Diluted) | 33.00 | 56.64 | 106.57 | 93.32 | 51.53 | Upgrade
|
| EPS Growth | -41.74% | -46.85% | 14.21% | 81.10% | 24.06% | Upgrade
|
| Free Cash Flow | 671,488 | 654,950 | 862,153 | 744,770 | 640,090 | Upgrade
|
| Free Cash Flow Per Share | 211.36 | 207.65 | 273.34 | 236.13 | 202.94 | Upgrade
|
| Dividend Per Share | - | 12.000 | - | - | 10.056 | Upgrade
|
| Gross Margin | 15.13% | 17.37% | 22.63% | 20.84% | 17.93% | Upgrade
|
| Operating Margin | 6.96% | 9.59% | 16.76% | 14.77% | 10.65% | Upgrade
|
| Profit Margin | 3.84% | 6.72% | 10.71% | 10.53% | 7.55% | Upgrade
|
| Free Cash Flow Margin | 24.60% | 24.64% | 27.47% | 26.65% | 29.75% | Upgrade
|
| EBITDA | 297,722 | 352,014 | 616,613 | 493,098 | 322,469 | Upgrade
|
| EBITDA Margin | 10.91% | 13.24% | 19.65% | 17.65% | 14.99% | Upgrade
|
| D&A For EBITDA | 107,676 | 96,951 | 90,745 | 80,415 | 93,406 | Upgrade
|
| EBIT | 190,046 | 255,063 | 525,868 | 412,683 | 229,064 | Upgrade
|
| EBIT Margin | 6.96% | 9.59% | 16.76% | 14.77% | 10.65% | Upgrade
|
| Effective Tax Rate | 22.02% | 24.89% | 22.09% | 22.04% | 16.87% | Upgrade
|
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.